Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data

被引：0
|
作者：
Kandemir, H. [1 ]
Karatas, A. [1 ]
Moral, K. [1 ]
Bilican, G. [1 ]
Kekilli, M. [1 ]
Cindoruk, M. [1 ]
Karakan, T. [1 ]
机构：
[1] Gazi Univ, Gastroenterol, Ankara, Turkiye
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0889
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0715
引用
收藏
页码：i1392 / i1393
页数：2
相关论文
共 50 条
  • [1] Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
    Erdogan, Cagdas
    Yesil, Bayram
    Bacaksiz, Ferhat
    Ari, Derya
    Gokbulut, Volkan
    Yuksel, Mahmut
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 831 - 837
  • [2] Single-Center Experience of Vedolizumab in Patients With Inflammatory Bowel Disease: Does Age Matter?
    Morganstern, Bradley
    Singh, Namita
    Targan, Stephan
    Landers, Carol J.
    Nguyen, Minh
    Vasiliauskas, Eric A.
    Shih, David
    Feldman, Edward J.
    Ippoliti, Andrew
    McGovern, Dermot
    Dubinsky, Marla
    Rabizadeh, Shervin
    Melmed, Gil Y.
    GASTROENTEROLOGY, 2015, 148 (04) : S250 - S250
  • [3] SINGLE CENTER EXPERIENCE OF LONG TERM VEDOLIZUMAB EFFICACY IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Singh, Namita
    Dubinsky, Marla
    Singh, Avantika
    Check, Morgan
    Rabizadeh, Shervin
    GASTROENTEROLOGY, 2017, 152 (05) : S959 - S960
  • [4] Infliximab Retreatment in Inflammatory Bowel Disease: A Single-center Experience
    Hughes, Julia
    Herfarth, Hans
    Isaacs, Kim
    Plevy, Scott
    Sartor, Balfour
    Sheikh, Shehzad
    Hansen, Jonathan
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S543 - S543
  • [5] Cancer surveillance in inflammatory bowel disease: A single-center experience
    Wong, Hang Hoi Michael
    Tze, Ying Ki Shirley
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 130 - 131
  • [6] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [7] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [8] Vedolizumab Therapy With or Without an Immunosuppressant for the Therapy of Inflammatory Bowel Disease: A Single Center Experience
    Chilukuri, Prianka
    Xu, Huiping
    Bohm, Matthew
    Sagi, Sashivar
    Fischer, Monika
    GASTROENTEROLOGY, 2016, 150 (04) : S812 - S813
  • [9] Description of Outcomes of Inflammatory Bowel Disease Patients With Granuloma on Histology: A Single-Center Experience
    Wehbe, Hisham
    Hosni, Mohamad
    Tamim, Hani
    Hashash, Jana
    Binion, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S28 - S28
  • [10] Characteristics and outcomes of rectal cancer in patients with inflammatory bowel disease: a single-center experience
    Emile, Sameh Hany
    Horesh, Nir
    Garoufalia, Zoe
    Rogers, Peter
    Gefen, Rachel
    Dasilva, Giovanna
    Wexner, Steven D.
    UPDATES IN SURGERY, 2024, 76 (01) : 119 - 126
12345